Published in

Oxford University Press, The Journal of Infectious Diseases, 4(207), p. 656-660, 2012

DOI: 10.1093/infdis/jis725

Links

Tools

Export citation

Search in Google Scholar

NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections

Journal article published in 2012 by Anne C. Teirlinck, Meta Roestenberg, Marga van de Vegte-Bolmer, Anja Scholzen, M. G. van de Vegte-Bolmer, Moniek J. L. Heinrichs, Rianne Siebelink-Stoter, Wouter Graumans, Geert-Jan van Gemert, G. J. A. van Gemert, Karina A. E. M. Teelen, Martijn W. Vos, C. Krystelle Nganou-Makamdop, Steffen Borrmann ORCID, Yolanda P. A. Rozier and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

We established a new field clone of Plasmodium falciparum for use in controlled human malaria infections and vaccine studies to complement the current small portfolio of P. falciparum strains, primarily based on NF54. The Cambodian clone NF135.C10 consistently produced gametocytes and generated substantial numbers of sporozoites in Anopheles mosquitoes and diverged from NF54 parasites by genetic markers. In a controlled human malaria infection trial, 3 of 5 volunteers challenged by mosquitoes infected with NF135.C10 and 4 of 5 challenged with NF54 developed parasitemia as detected with microscopy. The 2 strains induced similar clinical signs and symptoms as well as cellular immunological responses. CLINICAL TRIALS REGISTRATION: NCT01002833.